With broad technical expertise and cross-border capabilities, Dechert LLP represents clients in the life sciences industries before a variety of patent litigation venues. The group has a particularly strong appellate practice and also fields significant experience acting on behalf of petitioners and patent owners in Patent Trial and Appeal Board proceedings relating to pharmaceutical and biologic products. Trial lawyer Martin Black in Philadelphia leads the firm’s national IP litigation group, which also includes New York life sciences litigator Katherine Helm, who represents innovator pharmaceutical and biotech companies in both patent and patent-related litigation, and Amanda Antons in Chicago, who is highly experienced in ANDA litigation.
Key clients
- Biogen
- Dana-Farber Cancer Institute
- Eli Lilly and Company
- Endo Pharmaceuticals
- Gatekeeper Inc.
- IOENGINE, LLC
- IPCom GMBH & Co. KG
- Microsoft Corporation
- Mondis Technology, Ltd.
- Hitachi Maxell, Ltd.
- Sanofi SA
- Genzyme Corporation
- Tekni-Plex, Inc.
- True Spec Golf, LLC
- Zillow Group
Work highlights
- Represented Genzyme, a fully owned subsidiary of Sanofi, in two patent infringement actions in the District of Delaware and in defending its patents at the PTAB related to Sanofi Genzyme’s patents infringed by Novartis’ manufacture, sale and use of ZOLGENSMA®.
- Advised Hitachi, Ltd. and Mondis Technology on a licensing and litigation campaign.
Practice head
The lawyer(s) leading their teams.
Martin Black